Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A

Open Access

Peer-reviewed

Research Article

Amy Nowack ,

Contributed equally to this work with: Amy Nowack, Erik B. Malarkey

Affiliation Department of Pharmacology, University of Washington, Seattle, Washington, United States of America
⨯
Erik B. Malarkey ,

Contributed equally to this work with: Amy Nowack, Erik B. Malarkey

Affiliation Department of Pharmacology, University of Washington, Seattle, Washington, United States of America
⨯
Jia Yao,

Affiliation Department of Pharmacology, University of Washington, Seattle, Washington, United States of America
⨯
Adam Bleckert,

Affiliation Graduate Program in Neurobiology and Behavior, University of Washington, Seattle, Washington, United States of America
⨯
Jessica Hill,

Affiliation Department of Pharmacology, University of Washington, Seattle, Washington, United States of America
⨯
Sandra M. Bajjalieh

* E-mail: bajjalie@u.washington.edu

Affiliation Department of Pharmacology, University of Washington, Seattle, Washington, United States of America
⨯

Reader Comments (0)

Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Synapses
Is the Subject Area "Synapses" applicable to this article?

Thanks for your feedback.
Neurotransmission
Is the Subject Area "Neurotransmission" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.
Depression
Is the Subject Area "Depression" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Neurites
Is the Subject Area "Neurites" applicable to this article?

Thanks for your feedback.